Pain following Yoon fallopian ring application for tubal sterilization is a cause of prolonged recovery time in the ambulatory surgery patient. J-3 Cramping and generalized pelvic pain may require significant amounts of narcotic analgesics. For the ambulatory surgical patient, sedation, natisea, vomiting and respiratory depression caused by narcotic analgesics may slow recovery and be responsible for an overnight admission to the hospital a Attempts to limit pain following tubal sterilization have included the use of narcotic analgesics intraoperatively; spraying or topical application of local anaesthetics onto the fallopian tubes; and injecting the fallopian tubes with a local anaesthetic agent when surgery was performed with local anaesthesia, s-9 More recently, etidocaine one per cent has been applied topically to the fallopian tubes prior to banding, resulting in a reduction of nausea, vomiting and need for postoperative narcotic analgesics. 9 In this study the effects of mesosalpinx infiltration (beneath the area of fallopian rin=~ application) with lidocaine one per cent, bupivanaine 0.5 per cent, or normal saline on reported pain intensity of patients in the postanaesthesia care unit (PACU) were compared to a control group who received no injection.
Methods
The study was approved by the Institutional Review Board of the Methodist Medical Center of Illinois. One hundred females of ASA physical status I or [I, ranging in age from 21 to 40, scheduled for elective laparoseopic sterilization with Yoon fallopian rings were chosen consecutively for the study and randomly assigned to one of four groups. Informed consent was obtained from all subjects.
Patients came to the ambulatory surgery centre two to seven days before their surgery for preanaesthetic evaluation and testing. At this time, the patients received an explanation of the self assessment pain intensity scale (Figure) . This scale, which. has been in use at The Methodist Medical Center of Illinois Pain Management Clinic for seven years, was adapted from the horizontal graphic rating sale) ~ To enhance its sensitivity, key FIGURE Self-assessment pain intensity scape.
descriptive phrases were associated with the numbers on the scale. For example, a "10" on the scale was described as "pain as bad as it could be" while "0" was described as "no pain," with the mid-section labeled "moderate."
Patients were instructed on the use of numerical responses to standard questions that would be asked of them regarding postoperative levels of pain associated with the area of the ring application (e.g., "deep pain"). These instructions were reinforced preoperatively by nursing personnel on the day of surgery. Even though different nurses interviewed the patients, all instructions and questions were standardized. All study patients received premedication with atropine 0.3 mg 1M 30-45 minutes prior to surgery. Anaesthesia induction consisted of: d-tubocurarine 0.05mg-kg -l, thiopentone 4-5 mg.kg-t, fentanyl 1.5 I~g-kg-=, succinytcholine 1 mg.kg -~ and droperidol 0.009mg.kg -~. Following tracheal intubation, mlaesthesia was maintained with ni~'ous oxide and oxygen (3:2L.min -I) and isoflurane. A succinylcholine drip (0.2 per cent) provided muscle relaxation as needed throughout the procedure.
The surgical technique consisted of insertion of a Veres needle and insufflation of the peritoneal cavity with carbon dioxide, followed by insertion of a troear and laparoscopie application of Yoon fallopian rings Following fallopian ring application, a 20-gauge spinal needle was inserted suprapubically through the skin into the peritoneal cavity. Under direct vision, the mesosalpinx distal to the area of the ring placement was infiltrated (2.5 m] per side) with either lidoeaine one per cent (Group I), bupivacaine 0.5 per cent (Group 1I), or normal saline (Group III)~ Solutions were unknown to the gynaecologist, anaesthetist and operating room nurses. Controls (Group IV) received no infiltration. Following completion of surgery and anaesthesia, patients were taken to the PACU for monitoring of vital signs and pain levels. The patients' infiltration medication group was not known by the PACU staff.
Patients were questioned regarding their pain level by the PACU nurse at four times. Time one was 15 minutes after scoring ten on their Aldrete posmnaesthesia recovery score (APARS); 11 time two was just prior to ambulation; time three was just prior to discharge; and time four was at nine a.m. the morning following surgery. Pain levels were reported by patients based on the self-assessment pain intensity scale with scores from 0 to 10 as previously discussed. After the first measurement of pain intensity, fentanyl 12.5 Ixg was administered IV every five minutes by the PACU nurse for pain requiring analgesic medication. The fentanyl dose was not to exceed 50 I~g in the postanaesthesia recovery period without evaluation by the anaesthetist. Upon discharge from the facility patients were given tablets of acetaminophen with 30 mg codeine to be taken at home, as needed for pain.
Comparison of the means for pain intensity of the four groups were done by the Kruskall-Wallis H-Test; pairwise comparisons were done by Wileoxen's Rank-Sum Test for two independent samples. One-way analysis of variance (ANOVA) and Duncan's Multiple-Range Test were used to interpret pain medication data. Results for all tests were considered significant at p < 0.05.
Results
The four groups of study subjects were comparable in age (21-40), weight (48-86 kg) and general health (ASA physical status I or I1). No side effects of the drugs were reported.
Patients who received bnpivacaine 0.5 per cent (Group II) reported lower levels of pain intensity at all study times (Tables I-IV) . Analysis of responses to the self-assessment pain intensity scale using the Kruskall-Wallis H Test indicated the difference among groups was statistically significant (p < 0.05) only at study time one. From these results, it can be concluded that bupivacaine 0.5 per cent provided greater pain relief, based on responses to the self-assessment pain intensity scale, than the other treatments, but only at 15 minutes after the patients scored ten on the APARS. A pairwise comparison of groups by Wilcoxen's Rank-Sum test provides additional insights into the clinical implications of the groups. This test supports the superior results for bupivacaine 0.5 per cent at study time 1 (p < 0.05). The bupivacaine group had significantly less reported pain when compared to every other group. At study time two, WJlcoxen's Rank-Sum Test indicates that reported pain intensity was significantly lower for the bupivacaine 0.5 per cent group than the lidocaine group (p < 0.05). Wilcoxen's Rank-Sum test results ~howed no statistically significant difference between pairs of groups at study points three and four.
Patients who received bupivaeaine 0.5 per cent required significantly less fentanyl supplementation in the postoperative period (mean 4.9 lag; SE 3.0) than all other groups. B used on the patients' requests for and the amount of analgesics received postoperatively, the bupivacaine 0.5 per cent treatment offered greater pa~n relief (p < 0.05)
Discussion
To accept the conclusion that bupivacaine 0.5 per cent provides greater pain relief than lidocaine, saline or no infiltration, two assumptions must be made. First, the effects of drugs given during anaesthesia were the same or similar for all patients. Secondly, the drugs given during anaesthesia did not confound the effects of the b~piva-eaine, lidocaine or normal saline. These assumptions are reasonable since no interactions among the drugs given during anuesthesi:~ and the test group drugs are documented, t2 Because of the shoo duration of low dose fentanyl t3 given during anaesthetic induction, the analgesic effects probably did not play a major role in pain relief after the patients reached the first mcasnrcment time. (Usual duration of analgesic action after a single IV dose of fentanyl up to 100 ;zg is 30-60 minutes.) 13 The length of time between the initial fentanyl dose during anaesthesia induction and the initial measurement of pain intensity was not less than 45 minutes for all cases. After the first pain intensity measurement, fentanyl (12.5 p.g) was given to patients every five minutes as needed by the patient for pain. The analgesic effect of this drug would cause patients to report lower levels of pain than if they had received no postoperative medicine Although it is known how much fentanyt each group received, it is not known when it was given. Documentation of fentanyl administration times might indicate when patients in each group had the highest pain intensity. The effects of fentanyl on pain intensity may explain why the saline group had less pain than the lidocaine group at time two and the control group had less pain than the saline group at time three.
To further document the effects of bupivacaine 0.5 per cent on pain relief in Yoon fallopian ring application, replications of this study should be done. The amount of fentanyl given during each measurement interval should be documented so that additional inferences about levels of pain can be made.
Although different nurses interviewed the patients, observer and respondent bias should have been kept at a minimum due to the standardization instrument, the type of scale used for this study provides the best method for measuring pain or pain relief, to This initial study indicates bupivacaine 0.5 per cent is the preferred drug for infiltation of the mesosalpinx for pain relief following Yoon ring application of the fallopian tube.
